Here, we test the therapeutic potential of selectively inhibiting MMP14 using an affinity matured exosite inhibitor termed E2C6 with the primary aim of preventing endothelial Tie2 shedding in vitro in endothelial cells (ECs) and in vivo in murine sepsis and endotoxemia models. This evidence concerns the gene TEK and Sepsis.